Digital 2026: When clinical intelligence moves from promise to pract... We are about to enter a new era of clinical intelligence. The era of "digital" as a separate activity in healthcare will begin to dissolve in 2026.
News Hengrui gets first OK for a PD-L1/TGF-beta drug for cancer Hengrui has achieved a milestone in oncology as retlirafusp alfa is approved in China, its first world market, for gastric cancer.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.